- This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge.
- Other featured articles discuss how to find rising dividends, why some electric vehicle start-ups are in trouble and whether the shine is off big tech stocks after earnings.
- Also, see the prospects for a British pharmaceutical company, a travel recovery play, a recovering semiconductor leader, an industrial conglomerate and more.
"Infrastructure Is on Its Way. Here's a Cheap Way to Play It" by Nicholas Jasinski explains how Atlas Technical Consultants Inc ATCX is well positioned to benefit from the long-awaited infrastructure-investment bill, as it provides engineering and design services, inspection and certification of buildings and public works and other construction-related services.
In "Buy Glaxo Stock. An Activist Wants to Accelerate Its Turnaround," Josh Nathan-Kazis discusses why the long-awaited turnaround for British drugmaker GlaxoSmithKline plc GSK could soon be at hand, with some nudging from activist hedge fund Elliott Management. Could the stock run reclaim its all-time high above $75 a share?
Lawrence C. Strauss's "This Algorithm Finds Stocks Ripe for Higher Dividends" suggests that, while U.S. dividends have returned to normal levels, they could be headed up to 30% higher by the end of 2022. Barron's believes Goldman Sachs Group Inc GS, Morgan Stanley MS and more could lead the way.
With the Delta variant of coronavirus shaking things up, the health care sector has started gaining momentum, rising more in the past three months than any other sector. So says "Ride the Healthcare Rally" by Ben Levisohn. Find out why Barron's considers Pfizer Inc. PFE to be a prime example of that.
In Al Root's "EV Balance Sheet Checkup," discover why investors have serious doubts about some EV start-ups and stocks such as Lordstown Motors Corp RIDE and Nikola Corporation NKLA might not rebound anytime soon.
"Intel's New CEO Vows to Move Faster. Will It Help the Stock?" by Jack Hough points out that, under new leadership, Intel Corporation INTC is working to recapture its past glory in the semiconductor industry. However, bulls and bears are split on its chances of success, according to Barron's. Can it reclaim its technology lead by 2025 as the new CEO suggests?
Apple Inc AAPL, Microsoft Corporation MSFT and the rest of the world's five largest tech companies spent the pandemic making gobs of money, according to Eric J. Savitz's "Big Tech Earnings Sparkled—Now the Shine May Be Fading. However, e-commerce is slowing and the furious shopping spree for home offices and virtual schooling is probably coming to an end.
In "The Travel Theme Has Legs. AmEx Stock Is a Way to Play It," Steven M. Sears makes a case for using options on American Express Company AXP as a way to bet on the rebound in travel, despite the risks of a COVID-19 resurgence. See how much Barron's believes the stock could soar as Americans hit the road.
Al Root's "GE Has a No-Drama Earnings Beat, Powered by Its Free Cash Flow" claims that, ever since Larry Culp arrived at General Electric Company GE to turn the industrial conglomerate around, investors have worried about the company's meager cash flow. Now, that's not a problem, says the article, and bearish analysts have disappeared.
See also: How to Buy General Electric (GE) Stock
Also in this week's Barron's:
- Why the labor shortage is worse than it appears
- How the battle over closed-end funds could help and hurt investors
- How restaurants have catered to changing tastes over the past century
- Whether the market is sturdier than the tech sell-off suggests
- How stocks are entering the most dangerous stretch of the year
- Why there are plenty of jobs and still unemployment
- How a tattered care economy is holding back workers
- What it will take for gold prices to rally
- Why vaccine mandates could be good news for vaccine makers
- How to align the pursuit of early retirement with ESG ideals
At the time of this writing, the author had no position in the mentioned equities.
Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.